[go: up one dir, main page]

BR0213734A - Derivados de carboxamida heteroaromático para o tratamento de inflamação - Google Patents

Derivados de carboxamida heteroaromático para o tratamento de inflamação

Info

Publication number
BR0213734A
BR0213734A BR0213734-8A BR0213734A BR0213734A BR 0213734 A BR0213734 A BR 0213734A BR 0213734 A BR0213734 A BR 0213734A BR 0213734 A BR0213734 A BR 0213734A
Authority
BR
Brazil
Prior art keywords
inflammation
carboxamide derivatives
treatment
heteroaromatic carboxamide
heteroaromatic
Prior art date
Application number
BR0213734-8A
Other languages
English (en)
Inventor
Matthew Graneto
Cathleen E Hanau
Thao D Perry
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0213734A publication Critical patent/BR0213734A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

"DERIVADOS DE CARBOXAMIDA HETEROAROMáTICO PARA O TRATAMENTO DE INFLAMAçãO". A presente invenção refere-se a derivados de carboxamida heteroaromático, composições compreendendo os mesmos, intermediários, métodos de fabricar derivados de carboxamida heteroaromático e métodos para tratamento de câncer, inflamação e distúrbios associados à inflamação como artrite.
BR0213734-8A 2001-10-30 2002-10-30 Derivados de carboxamida heteroaromático para o tratamento de inflamação BR0213734A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34081601P 2001-10-30 2001-10-30
PCT/US2002/034801 WO2003037886A2 (en) 2001-10-30 2002-10-30 Heteroaromatic carboxamide derivatives for the treatment of inflammation

Publications (1)

Publication Number Publication Date
BR0213734A true BR0213734A (pt) 2004-10-19

Family

ID=23335051

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213734-8A BR0213734A (pt) 2001-10-30 2002-10-30 Derivados de carboxamida heteroaromático para o tratamento de inflamação

Country Status (7)

Country Link
EP (1) EP1444010A2 (pt)
JP (1) JP2005509645A (pt)
AU (1) AU2002356871A1 (pt)
BR (1) BR0213734A (pt)
CA (1) CA2464924A1 (pt)
MX (1) MXPA04004064A (pt)
WO (1) WO2003037886A2 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4364120B2 (ja) 2002-06-06 2009-11-11 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換３−アミノ−チエノ［２，３−ｂ］ピリジン−２−カルボン酸アミド化合物、その製造方法及び使用
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
AU2003270701B2 (en) 2002-10-31 2009-11-12 Amgen Inc. Antiinflammation agents
US7329764B2 (en) 2003-07-31 2008-02-12 Boehringer Ingelheim Pharmaceuticals, Inc. Substitute benzothiophene compounds
FR2860792B1 (fr) 2003-10-10 2006-02-24 Sanofi Synthelabo Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique
US7119102B2 (en) 2003-12-05 2006-10-10 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
US7470701B2 (en) 2004-03-30 2008-12-30 Novartis Vaccines And Diagnostics, Inc. Substituted 2,5-heterocyclic derivatives
TW200616967A (en) 2004-06-24 2006-06-01 Smithkline Beecham Corp Novel indazole carboxamides and their use
TW200626142A (en) 2004-09-21 2006-08-01 Glaxo Group Ltd Chemical compounds
JP5117374B2 (ja) 2005-03-29 2013-01-16 イコス・コーポレイション Ｃｈｋ１阻害に有用なヘテロアリール尿素誘導体
GB0507200D0 (en) * 2005-04-08 2005-05-18 Smithkline Beecham Corp Chemical compounds
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
EA014083B1 (ru) 2005-06-30 2010-08-30 Смитклайн Бичам Корпорейшн Новые производные индолкарбоксамида, содержащая их фармацевтическая композиция и способ лечения
EP2474546A1 (en) 2006-01-23 2012-07-11 Vertex Pharmaceuticals Inc. Thiophene-carboxamides useful as inhibitors of protein kinases
JP2009533452A (ja) * 2006-04-13 2009-09-17 バーテックス ファーマシューティカルズ インコーポレイテッド タンパク質キナーゼの阻害剤として有用なチオフェン−カルボキサミド
CA2650290C (en) 2006-04-26 2015-11-17 Genentech, Inc. Pharmaceutical compounds
JP2009538309A (ja) * 2006-05-23 2009-11-05 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド
CN101495474A (zh) 2006-05-23 2009-07-29 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的噻吩-甲酰胺类
WO2007146602A1 (en) 2006-06-06 2007-12-21 Boehringer Ingelheim International Gmbh Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
JPWO2008020622A1 (ja) * 2006-08-17 2010-01-07 杏林製薬株式会社 新規なチエノ［２，３−ｄ］ピリミジン化合物
MY180595A (en) 2006-12-07 2020-12-03 Genentech Inc Phosphoinositide 3-kinase inhibitor compounds and methods of use
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
CN101932587A (zh) 2007-09-24 2010-12-29 吉宁特有限公司 噻唑并嘧啶pi3k抑制剂化合物及使用方法
JP5421925B2 (ja) 2007-12-19 2014-02-19 ジェネンテック， インコーポレイテッド ５−アニリノイミダゾピリジン及び使用の方法
ES2387707T3 (es) 2007-12-21 2012-09-28 Genentech, Inc. Azaindolizinas y procedimientos de uso
CA2750519C (en) 2009-02-05 2018-09-25 Immunogen, Inc. Benzodiazepine derivatives
EP2406249A1 (en) 2009-03-10 2012-01-18 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
CA2753285A1 (en) 2009-03-12 2010-09-16 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
AU2010236980A1 (en) * 2009-04-16 2011-11-10 Telik, Inc. Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors
WO2011036284A1 (en) 2009-09-28 2011-03-31 F. Hoffmann-La Roche Ag Benzoxepin pi3k inhibitor compounds and methods of use
WO2011049625A1 (en) 2009-10-20 2011-04-28 Mansour Samadpour Method for aflatoxin screening of products
CA2779574C (en) 2009-11-05 2018-12-18 Rhizen Pharmaceuticals S.A. Novel kinase modulators
MX341687B (es) 2010-02-10 2016-08-30 Immunogen Inc "anticuerpos cd20 y su utilización".
SG191965A1 (en) 2011-02-15 2013-08-30 Immunogen Inc Methods of preparation of conjugates
AP4075A (en) 2011-05-04 2017-03-23 Rhizen Pharmaceuticals S A Novel compounds as modulators of protein kinases
KR101915942B1 (ko) 2012-06-08 2018-11-06 에프. 호프만-라 로슈 아게 암의 치료를 위한 포스포이노시타이드 3 키나제 억제제 화합물 및 화학치료제의 돌연변이체 선택성 및 조합물
DK3260455T3 (da) 2012-07-04 2019-06-11 Rhizen Pharmaceuticals S A Selektive pi3k delta-hæmmere
WO2014031566A1 (en) 2012-08-22 2014-02-27 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
EP2961435B1 (en) 2013-02-28 2019-05-01 ImmunoGen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
EP2961434A2 (en) 2013-02-28 2016-01-06 ImmunoGen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014194030A2 (en) 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
AR104068A1 (es) 2015-03-26 2017-06-21 Hoffmann La Roche Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer
WO2018045379A1 (en) 2016-09-02 2018-03-08 Dana-Farber Cancer Institute, Inc. Composition and methods of treating b cell disorders
EP4234536A3 (en) * 2017-05-05 2023-10-25 Hepanova, Inc. Amino-aryl-benzamide compounds and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1360982A (en) * 1970-08-27 1974-07-24 Beecham Group Ltd Derivatives of 1-phenyl-5-aminoimidazole and compositions thereof
US3864359A (en) * 1972-05-01 1975-02-04 American Cyanamid Co 5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and method of preparation thereof
US4264495A (en) * 1972-05-15 1981-04-28 Eastman Kodak Company 2-Thienyl azo dyestuff compounds
GB1468012A (en) * 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DD236530A1 (de) * 1985-04-26 1986-06-11 Univ Halle Wittenberg Verfahren zur herstellung von 2-cyano-2-(4h-4-oxo-1,2,dihydro-thieno 2,3-d 1,3 thiazin-2-yliden)-essigsaeureestern
DD263055A1 (de) * 1987-07-28 1988-12-21 Univ Dresden Tech Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene
DE3914430A1 (de) * 1988-05-05 1989-11-16 Ciba Geigy Ag Azofarbstoffe, verfahren zu deren herstellung und deren verwendung
DE4019168A1 (de) * 1989-06-19 1990-12-20 Ciba Geigy Ag Azofarbstoffe, deren herstellung und verwendung
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
JP2002105081A (ja) * 2000-07-28 2002-04-10 Nikken Chem Co Ltd 新規チオフェンニ環化合物
AU2002211663A1 (en) * 2000-10-12 2002-04-22 Smith Kline Beecham Corporation Nf-$g(k)b inhibitors
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
WO2003028731A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors

Also Published As

Publication number Publication date
WO2003037886A2 (en) 2003-05-08
JP2005509645A (ja) 2005-04-14
EP1444010A2 (en) 2004-08-11
MXPA04004064A (es) 2004-09-06
CA2464924A1 (en) 2003-05-08
WO2003037886A3 (en) 2003-12-24
AU2002356871A1 (en) 2003-05-12

Similar Documents

Publication Publication Date Title
BR0213734A (pt) Derivados de carboxamida heteroaromático para o tratamento de inflamação
BR0212617A (pt) Compostos de pirazolila substituìdo para o tratamento de inflamação
BR0212613A (pt) Compostos de indazol substituìdos para o tratamento de inflamação
BR0212611A (pt) Compostos de pirazolila substituìdos para o tratamento da inflamação
BR0212661A (pt) Compostos de pirazolil benzenossulfamida substituìdos para o tratamento de inflamação
DOP2002000429A (es) Imidazotriazinas
NL300933I2 (nl) Letermovir
BR0307796A (pt) Derivados tricìclicos de pirazol para o tratamento de inflamação
NO20034056D0 (no) Proliferative sykdommer
WO2004041203A3 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
ATE408601T1 (de) Fredericamycin-derivate
DE60231439D1 (de) Mitotische kinesinhemmer
DE60234278D1 (de) Mitotische kinesin-hemmer
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
UY26130A1 (es) Compuestos para tratar la obesidad
EE200300559A (et) Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0312722A (pt) Derivados de pirazol heterobicìclico como inibidores de qinase
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
BR0117009A (pt) Composiçoes para utilização no tratamento de distúrbios associados a ige
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
NO20055307D0 (no) Substituerte isokromanforbindelser for behandling av metabolske forstyrrelser, kreft og andre sykdommer
EP1507778A4 (en) POLZYCLIC CARBOXYLAMIDE AMIDE WITH ANTITUMORIC EFFECT

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5O, 6O E 7O ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2034 DE 29/12/2009.

B15K Others concerning applications: alteration of classification

Ipc: C07D 333/38 (2006.01), A61P 29/00 (2006.01), C07D